BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number
Overview
Authors
Affiliations
BRCA1 functions as a tumor suppressor in DNA repair and centrosome regulation. Previously, Obg-like ATPase 1 (OLA1) was shown to interact with BARD1, a heterodimer partner of BRCA1. OLA1 binds to BRCA1, BARD1, and γ-tubulin and functions in centrosome regulation. This study determined that overexpression of wild-type OLA1 (OLA1-WT) caused centrosome amplification due to centriole overduplication in mammary tissue-derived cells. Centrosome amplification induced by overexpression of the cancer-derived OLA1 mutant, which is deficient at regulating centrosome number, occurred in significantly fewer cells than in that induced by overexpression of OLA1-WT. Thus, it was hypothesized that overexpression of OLA1 with normal function efficiently induces centrosome amplification, but not that of OLA1 mutants, which are deficient at regulating centrosome number. We analyzed whether overexpression of OLA1 missense mutants of nine candidate phosphorylation residues, three residues modified with acetylation, and two ATP-binding residues caused centrosome amplification and identified five missense mutants that are deficient in the regulation of centrosome number. Three of them did not bind to BARD1. Two phosphomimetic mutations restored the binding to BARD1 and the efficient centrosome amplification by their overexpression. Knockdown and overexpression of BARD1 also caused centrosome amplification. BARD1 mutant reported in cancer failed to bind to OLA1 and rescue the BARD1 knockdown-induced centrosome amplification and reduced its centrosomal localization. Combined, these data reveal that the OLA1-BARD1 interaction is important for the regulation of centrosome number. Regulation of centrosome number by BRCA1/BARD1 together with OLA1 is important for the genome integrity to prevent tumor development. .
Conserved GTPase OLA1 promotes efficient translation on D/E-rich mRNA.
Yu T, Li X, Dong W, Zhou Q, Li Q, Du Z Nat Commun. 2025; 16(1):1549.
PMID: 39934121 PMC: 11814078. DOI: 10.1038/s41467-025-56797-8.
Chen Z, Zeng L, Chen Z, Xu J, Zhang X, Ying H Technol Cancer Res Treat. 2024; 23:15330338241241935.
PMID: 38564315 PMC: 11007312. DOI: 10.1177/15330338241241935.
Chakraborty A, Halder S, Kishore P, Saha D, Saha S, Sikder K Genes Cells. 2022; 27(7):469-481.
PMID: 35610748 PMC: 9545696. DOI: 10.1111/gtc.12942.
Lavoro A, Scalisi A, Candido S, Zanghi G, Rizzo R, Gattuso G Int J Oncol. 2022; 60(5).
PMID: 35383859 PMC: 8997337. DOI: 10.3892/ijo.2022.5349.
Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer.
Wu J, Aini A, Ma B Mol Genet Genomic Med. 2022; 10(3):e1847.
PMID: 35084806 PMC: 8922950. DOI: 10.1002/mgg3.1847.